Nitric Oxide gas at 160ppm
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of British Columbia
Overview
Nitric Oxide gas at 160ppm is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Nitric Oxide gas at 160ppm clinical trials
Explore related
Medical disclaimer. This page summarizes research about Nitric Oxide gas at 160ppm for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.